Skip to main content
Log in

Production of autostimulatory growth factors by the human carcinoma line, RPMI 2650

  • Growth, Differentiation And Senescence
  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Summary

The human carcinoma line RPMI 2650 produces autocrine factors; they are detected by the ability of RPMI 2650 conditioned medium (CM) to stimulate growth in soft agar of RPMI 2650 cells plated at low density. The autocrine activity in crude CM can be fractionated by ultrafiltration into a lower molecular weight (MW) fraction (R1–30), which concentrates molecules in the 1000–30 000 Da range; and a higher MW fraction (R30) with molecules greater than 30 000 Da in a more concentrated form. R1–30 is labile to acid, base, and heat treatment, whereas R30 is stable to (and sometimes activated by) these treatments. Boiling of R30, however, renders it labile to acid, base, and trypsin treatments. CM can be separated into a weakly heparin-binding fraction (with stability properties similar, but not identical, to R1–30), and a non-heparin binding fraction (with stability properties similar to R30). RPMI 2650 cells secrete transforming growth factor (TGF)α- and TGFβ-like molecules, but the R1–30 fraction can be distinguished from these TGFs, and from most other known growth factors, by its unusual combination of acid lability and weak affinity for heparin. Since the R30/non-heparin binding fraction is rendered labile by boiling or acid treatment, it may represent a bound or conformationally stable form of a growth factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arai, K.; Lee, F.; Miyajima, A., et al. Cytokines: co-ordinators of immune and inflammatory responses. Ann. Rev. Biochem. 59:783–836; 1990.

    Article  PubMed  CAS  Google Scholar 

  2. Bazill, G. W.; Haynes, M.; Garland, J., et al. Characterization and partial purification of a haemopoietic cell growth factor in WEH1-3 cell conditioned medium. Biochemistry J. 210:747–759; 1983.

    CAS  Google Scholar 

  3. Blat, C.; Villaudy, J.; Delbe, J., et al. Purification from transformed mouse fiber of a cell growth inhibitor which is an IGF-binding protein. Growth Factors 6:65–75; 1992.

    PubMed  CAS  Google Scholar 

  4. Browder, T. M.; Dunbar, C.; Nierhuis, A. Private and public autocrine loops in neoplastic cells. Cancer Cells 1:9–17; 1989.

    PubMed  CAS  Google Scholar 

  5. Brown, C. A.; Halper, J. Mitogenic effects of transforming growth factor type e on epithelial and fibroblastic cells—comparison with other growth factors. Exp. Cell Res. 190:233–242. 1990.

    Article  PubMed  CAS  Google Scholar 

  6. Clark-Lewis, I.; Kent, S. B. H.; Schrader, J. W. Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells. Biol. Chem. 259:7488–7494; 1983.

    Google Scholar 

  7. Clynes, M.; Dooley, M.; Carey, B., et al.In vitro production of growth regulators for human epithelial cells. In: Spier, R. E.; Griffiths, J. B.; Meignier, B., eds. Production of biologicals from animal cells in culture. London: Butterworth-Heineman; 1991:932–734.

    Google Scholar 

  8. DeLarco, J. E.; Todaro, G. J. Growth factors from murine sarcoma virus transformed cells. Proc. Natl. Acad. Sci. USA 75:4001–4005; 1978.

    Article  CAS  Google Scholar 

  9. Dennis, P. A.; Sabsela, O.; Harper, P., et al.α 2-Macroglobulin is a binding protein for basic fibroblast growth factor. J. Biol. Chem. 264:7210–7216; 1989.

    PubMed  CAS  Google Scholar 

  10. Derynck, R.; Balentien, E.; Han, J. M., et al. Recombinant expression, biochemical characterisation and biological activities of the human MGSA/gro protein. Biochemistry 29:10225–10233; 1990.

    Article  CAS  Google Scholar 

  11. Deuel, T. F. Polypeptide growth factors: roles in normal and abnormal cell growth. Ann. Rev. Cell Biol. 3:443–492; 1987.

    PubMed  CAS  Google Scholar 

  12. Dunnington, D. J.; Scott, R. G.; Anzano, M. A., et al. Characterisation and partial purification of human epithelial transforming growth factor. J. Cell. Biochem. 44:229–239; 1990.

    Article  PubMed  CAS  Google Scholar 

  13. Finch, P. W.; Rubin, J. S.; Miki, T., et al. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245:752–755; 1989.

    Article  PubMed  CAS  Google Scholar 

  14. Glovine, F. S.; Duft, G. W. Molecular and functional aspects of human PRFs. In: Peptide regulatory factors. London: Lancet Series, Edward Arnold; 1989:125–155.

  15. Heldin, C. H.; Westermark, B. Growth factors as transforming proteins. Eur. J. Biochem. 184:487–496; 1989.

    Article  PubMed  CAS  Google Scholar 

  16. Higashiyama, S.; Abraham, J. A.; Miller, J., et al. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251:936–938; 1991.

    Article  PubMed  CAS  Google Scholar 

  17. Hilton, D. J.; Nicola, N. A.; Metcalf, D. Purification of a murine leukemia inhibitory factor from Krebs ascites cells. Anal. Biochem. 173:359–367; 1988.

    Article  PubMed  CAS  Google Scholar 

  18. Hirai, R.; Yamanoaka, K.; Mitsui, H. Isolation and partial purification of a new class of transforming growth factor from an avian sarcoma virus-transformed rat cell line. Cancer Res. 43:5742–5746; 1983.

    PubMed  CAS  Google Scholar 

  19. Hirano, T.; Taga, T.; Nakano, N., et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc. Natl. Acad. Sci. USA 82:5490–5494; 1985.

    Article  PubMed  CAS  Google Scholar 

  20. Huang, S.; O’Grady, P.; Huang, J. Human transforming growth factor-β α 2-macroglobulin complex is a latent form of transforming growth factorβ. J. Biol. Chem. 263:1535–1541; 1988.

    PubMed  CAS  Google Scholar 

  21. Huang, J. S.; Huang, S. S.; Deuel, T. F. Specific covalent binding of platelet-derived growth factor to human plasmaα 2-macroglobulin. Proc. Natl. Acad. Sci. USA 81:342–346; 1984.

    Article  PubMed  CAS  Google Scholar 

  22. Jaye, M.; Burgess, W. H.; Shaw, A. B., et al. Biological equivalence of natural bovine and recombinant humanα-endothelial cell growth factors. J. Biol. Chem. 262:16612–16617; 1987.

    PubMed  CAS  Google Scholar 

  23. Jubinsky, P. T.; Stanley, E. R. Purification of hemopoietin 1: A multilineage hemopoietic growth factor. Proc. Natl. Acad. Sci. USA 82:2764–2768; 1985.

    Article  PubMed  CAS  Google Scholar 

  24. Jullien, P.; Berg, T. M.; Lawrence, D. A. Acidic cellular environments: activation of latent TGFβ and sensitisation of cellular responses to TGFβ and EGF. Int. J. Cancer 43:886–891; 1989.

    Article  PubMed  CAS  Google Scholar 

  25. Li, Y.; Milner, P. G.; Chauhan, A. K., et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250:1690–1694; 1990.

    Article  PubMed  CAS  Google Scholar 

  26. Lobb, R. R.; Harper, J. W.; Fett, J. W. Purification of heparin-binding growth factors. Anal. Biochem. 154:1–14; 1986.

    Article  PubMed  CAS  Google Scholar 

  27. Lopez-Casillas, F.; Cheifetz, S.; Doody, J., et al. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67:785–795; 1991.

    Article  PubMed  CAS  Google Scholar 

  28. Lyons, R. M.; Moses, H. L. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187:467–473; 1990.

    Article  PubMed  CAS  Google Scholar 

  29. Merenmies, J.; Rauvala, H. Molecular cloning of an 18 kD growth-associated protein of developing brain. J. Biol. Chem. 265:16721–16724; 1990.

    PubMed  CAS  Google Scholar 

  30. Miyazono, K.; Hellman, V.; Wernstedt, C., et al. Latent high molecular weight complex of transforming growth factor-β1. J. Biol. Chem. 263:6407–6415; 1988.

    PubMed  CAS  Google Scholar 

  31. Moore, G.; Sandberg, A. Studies of a human tumor cell line, with a diploid karyotype. Cancer 117:170–173; 1963.

    Google Scholar 

  32. Moses, H. L.; Yong, E. Y.; Pietenpol, J. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245–247; 1990.

    Article  PubMed  CAS  Google Scholar 

  33. Myoken, Y.; Kayada, Y.; Okamoto, T., et al. Vascular endothelial cell growth factor (VEGF) produced by A431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc. Natl. Acad. Sci. USA 88:5819–5823; 1991.

    Article  PubMed  CAS  Google Scholar 

  34. Namen, A. E.; Schmierer, A. E.; March, C. J., et al. B-cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J. Exp. Med. 167:988–1002; 1988.

    Article  PubMed  CAS  Google Scholar 

  35. Nicola, N. A.; Metcalf, D.; Matsumoto, M., et al. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Biol. Chem. 258:9017–9023; 1983.

    CAS  Google Scholar 

  36. O’Connor-McCourt, M. D.; Wakefield, L. M. Latant transforming growth factor-β in serum. J. Biol. Chem. 262:14090–14099; 1987.

    PubMed  CAS  Google Scholar 

  37. Ohara, J.; Lahet, S.; Inman, J., et al. Partial purification of murine B cell stimulatory factor (BSF)-1. Immunology 135:2518–2523; 1985.

    CAS  Google Scholar 

  38. Peveri, P.; Walz, A.; Dewald, B., et al. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 167:1547–1559; 1988.

    Article  PubMed  CAS  Google Scholar 

  39. Rizzino, A.; Ruff, E. Fibroblast growth factor induces the soft agar growth of non-transformed cell lines. In Vitro Cell. Dev. Biol. 22:749–755; 1986.

    Article  PubMed  CAS  Google Scholar 

  40. Roberts, R.; Gallagher, J.; Spooner, E., et al. Heparin sulphate-bound growth factors, a mechanism for cell mediated haemopoiesis. Nature 332:376–378; 1988.

    Article  PubMed  CAS  Google Scholar 

  41. Rowe, J. M.; Kasper, S.; Shiu, R. P. C., et al. Purification and characterisation of a human tumor-derived growth factor. Cancer Res. 46:1408–1412; 1986.

    PubMed  CAS  Google Scholar 

  42. Rubin, J. S.; Osada, H.; Finch, P. W., et al. Purification and characterisation of a newly identified growth factor for epithelial cells. Proc. Natl. Acad. Sci. USA 86:802–806; 1989.

    Article  PubMed  CAS  Google Scholar 

  43. Sasoki, R.; Yanagawa, S. I.; Chuba, H. Isolation of human erythropoietin with monoclonal antibodies. Methods Enzymol. 147:328–340; 1987.

    Article  Google Scholar 

  44. Sauder, D. N.; Stanulis-Praeger, B. M.; Gilchrest, B. A. Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte-activating factor: implications for skin aging. Arch. Dermatol. Res. 280:71–76; 1988.

    Article  PubMed  CAS  Google Scholar 

  45. Schroder, J. M.; Mrowietz, U.; Christophers, E. Identification of different charged species of a human monocyte derived neutrophil activating peptide (MONAP). Biochem. Biophys. Res. Commun. 152:277–284; 1988.

    Article  PubMed  CAS  Google Scholar 

  46. Sero, M.; Sasada, R.; Kurokawa, T., et al. Carboxyl-terminal structure of basic fibroblast growth factor significantly contributes to its affinity for heparin. Eur. J. Biochem. 188:239–245; 1990.

    Article  Google Scholar 

  47. Shearer, M.; Taylor-Popadimitrou, J. Regulation of cell growth by interferon. Cancer Metastasis Rev. 6:199–221; 1987.

    Article  PubMed  CAS  Google Scholar 

  48. Sherry, B.; Cerami, A. Cachectin/tumor necrosis factor exerts endocrine, paracrine and autocrine control of inflammatory responses. J. Cell. Biol. 107:1270–1277; 1988.

    Article  Google Scholar 

  49. Slack, J. M. W.; Peptide regulatory factors in embryonic development. In: Peptide regulatory factors. London: Lancet Series, Edward Arnold; 1989 :91–101.

  50. Sporn, M. B.; Roberts, A. B. Peptide growth factors are multifunctional. Nature 332:217–219; 1988.

    Article  PubMed  CAS  Google Scholar 

  51. Stern, A. S.; Pan, Y. E.; Urdal, D. L., et al. Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia. Proc. Natl. Acad. Sci. USA 81:871–875; 1984.

    Article  PubMed  CAS  Google Scholar 

  52. Takatsu, K.; Kikuchi, Y.; Takahashi, T., et al. Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 84:4234–4238; 1987.

    Article  PubMed  CAS  Google Scholar 

  53. Van Zoelan, E. Phenotypic transformation of normal rat kidney cells: a model for studying cellular alterations in oncogenesis. Crit. Rev. Oncogenesis 2:311–333; 1991.

    Google Scholar 

  54. Watson, J. D.; Crossier, P. S.; March, C. J., et al. Purification to homogeneity of a human hematopoietic growth factor that stimulates the growth of a murine interleukin 3-dependent cell line. J. Immunol. 137:854–857; 1986.

    PubMed  CAS  Google Scholar 

  55. Wu, D.; Kan, M.; Sato, G. M., et al. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J. Biol. Chem. 266:16778–16785; 1991.

    PubMed  CAS  Google Scholar 

  56. Zarling, J. M.; Shoyab, M.; Marguert, H., et al. A growth regulator produced by differentiated histocytic lymphoma cells. Proc. Natl. Acad. Sci. USA 83:9739–9743; 1986.

    Article  PubMed  CAS  Google Scholar 

  57. Zarnegar, R.; Michalopoulos, G. Purification and biological characterisation of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 49:3314–3320; 1989.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carey, B.M., Dooley, M., Weedle, R. et al. Production of autostimulatory growth factors by the human carcinoma line, RPMI 2650. In Vitro Cell Dev Biol - Animal 29, 153–160 (1993). https://doi.org/10.1007/BF02630947

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02630947

Key words

Navigation